Evidence map›Paper›PMID 34830422›Full record

ArticleInternational journal of molecular sciences2021

Establishment of an Efficient Immortalization Strategy Using HMEJ-Based b

Zihan Zhang, Zhuo Han, Ying Guo, Xin Liu, Yuanpeng Gao, Yong Zhang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Immortalization Reversibility in the Context of Cell Therapy Biosafety.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zihan ZhangCollege of Veterinary Medicine, Northwest A&F University, Xianyang 712100, China.
Zhuo HanCollege of Veterinary Medicine, Northwest A&F University, Xianyang 712100, China.
Ying GuoCollege of Veterinary Medicine, Northwest A&F University, Xianyang 712100, China.
Xin LiuCollege of Veterinary Medicine, Northwest A&F University, Xianyang 712100, China.
Yuanpeng GaoCollege of Veterinary Medicine, Northwest A&F University, Xianyang 712100, China.
Yong ZhangCollege of Veterinary Medicine, Northwest A&F University, Xianyang 712100, China.
Ministry of Agriculture and Rural Affairs · CNNorthwest A&F University · CN

Funding

Ministry of Agriculture of China No. 2016ZX08007003
6 · The paper itself

Abstract

Immortalized cell lines have been used in a wide range of applications in research on immune disorders and cellular metabolic regulation due to the stability and uniformity of their cellular characteristics. At present, the investigation into molecular functions and signaling pathways within bovine cells remains largely limited by the lack of immortalized model cells. Current methods for immortalizing bovine cells are mainly restricted to the ectopic expression of human telomerase reverse transcriptase (hTERT) through transient transfection or virus-mediated delivery, which have defects in efficiency and reliability. In this study, we identified bovine TERT (bTERT) as a novel potent biofactor for immortalizing bovine cells with great advantages over hTERT, and established an efficient and easily manipulated strategy for the immortalization of bovine primary cells. Through the homology-mediated end-joining-based insertion of bTERT at the ROSA26 locus, we successfully generated immortalized bovine fetal fibroblast cell lines with stable characteristics. The observed limitation of this strategy in immortalizing bovine bone marrow-derived macrophages was attributed to the post-translational modification of bTERT, causing inhibited nuclear localization and depressed activity of bTERT in this terminally differentiated cell. In summary, we constructed an innovative method to achieve the high-quality immortalization of bovine primary cells, thereby expanding the prospects for the future application of immortalized bovine model cell lines.

Indexed as

AnimalsCattleCell Line, TransformedDNA End-Joining RepairGene Expression Regulation, EnzymologicHumansRecombinational DNA RepairTelomeraseTelomeraseTERT protein, humanbovineCRISPR/Cas9homology-mediated end joining (HMEJ)immortalizationmacrophagetelomerase reverse transcriptase (TERT)

Identifiers

PMID34830422
PMCPMC8622252
OpenAlexW3215760457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.